The impact of the Cancer Genome Atlas on lung cancer

被引：88
|
作者：
Chang, Jeremy T. -H.
Lee, Yee Ming
Huang, R. Stephanie
机构：
[1] Univ Chicago, Biol Sci Collegiate Div, Chicago, IL 60637 USA
[2] Univ Chicago, Ctr Personalized Therapeut, Chicago, IL 60637 USA
[3] Univ Chicago, Dept Med, Chicago, IL 60637 USA
来源：
TRANSLATIONAL RESEARCH | 2015年 / 166卷 / 06期
关键词：
MESSENGER-RNA; COPY NUMBER; TRANSCRIPTIONAL REGULATION; 1ST-LINE TREATMENT; TUMOR-SUPPRESSOR; OPEN-LABEL; EXPRESSION; GENE; CHEMOTHERAPY; MUTATION;
D O I：
10.1016/j.trsl.2015.08.001
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
The Cancer Genome Atlas (TCGA) has profiled more than 10,000 samples derived from 33 types of cancer to date, with the goal of improving our understanding of the molecular basis of cancer and advancing our ability to diagnose, treat, and prevent cancer. This review focuses on lung cancer as it is the leading cause of cancer-related mortality worldwide in both men and women. Particularly, non-small cell lung cancers (including lung adenocarcinoma and lung squamous cell carcinoma) were evaluated. Our goal was to demonstrate the impact of TCGA on lung cancer research under 4 themes: diagnostic markers, disease progression markers, novel therapeutic targets, and novel tools. Examples are given related to DNA mutation, copy number variation, messenger RNA, and microRNA expression along with methylation profiling.
引用
收藏
页码：568 / 585
页数：18
相关论文
共 50 条
  • [1] Cancer genome atlas
    Hampton, Tracy
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (16): : 1958 - 1958
  • [2] The Cancer Genome Atlas
    Muddabhaktuni, B. Minu Chandra
    Koyyala, Venkata Pradeep Babu
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (04) : 353 - 355
  • [3] The Cancer Genome Atlas Impact and Future Directions in Sarcoma
    Burns, Jessica
    Brown, Jeffrey M.
    Jones, Kevin B.
    Huang, Paul H.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2022, 31 (03) : 559 - 568
  • [4] Impact of genetic alterations on outcomes of patients with stage I nonsmall cell lung cancer: An analysis of the cancer genome atlas data
    Xu, Song
    Wang, Yanye
    Ren, Fan
    Li, Xiongfei
    Ren, Dian
    Dong, Ming
    Chen, Gang
    Song, Zuoqing
    Chen, Jun
    CANCER MEDICINE, 2020, 9 (20): : 7686 - 7694
  • [5] Misuse of The Cancer Genome Atlas?
    Bhangoo, Sandeep S.
    JOURNAL OF NEUROSURGERY, 2015, 123 (06) : 1609 - 1610
  • [6] The Cancer Genome Atlas: Clinical Applications for Breast Cancer
    Ma, Cynthia X.
    Ellis, Matthew J.
    ONCOLOGY-NEW YORK, 2013, 27 (12): : 1263 - +
  • [7] Progress in The Cancer Genome Atlas bladder cancer project
    Weinstein, John N.
    Kim, Jaegil
    Creighton, Chad J.
    Akbani, Rehan
    Hoadley, Katherine A.
    Kim, William Y.
    Morgan, Margaret B.
    Hinoue, Toshinori
    Cherniack, Andrew
    Su, Xiaoping
    Mungall, Andrew J.
    Ryan, Michael C.
    Bajorin, Dean F.
    Rosenberg, Jonathan E.
    Czerniak, Bogdan
    Hansel, Donna
    Reuter, Victor E.
    Robinson, Brian D.
    Al-Ahmadie, Hikmat A.
    Damrauer, Jeffrey S.
    Zhang, Wei
    Liu, Yuexin
    Gordenin, Dmitry R.
    Stuart, Joshua M.
    Schultz, Nikolaus
    Robertson, Gordon
    Jones, Steven J. M.
    Kucherlapati, Raju R.
    McConkey, David J.
    Laird, Peter W.
    Mills, Gordon B.
    Kwiatkowski, David J.
    Lerner, Seth P.
    CANCER RESEARCH, 2015, 75
  • [8] The Cancer Genome Atlas maps papillary thyroid cancer
    David Killock
    Nature Reviews Clinical Oncology, 2014, 11 (12) : 681 - 681
  • [9] The Cancer Genome Atlas output and practice of gastric cancer
    Sugimura, Haruhiko
    TRANSLATIONAL GASTROINTESTINAL CANCER, 2015, 4 (02) : 115 - 117
  • [10] NIH to build cancer genome atlas
    不详
    CHEMICAL & ENGINEERING NEWS, 2005, 83 (51) : 36 - 36
12345